To amend the Federal Food, Drug, and Cosmetic Act to encourage innovation and increase and protect consumer access with respect to dietary supplements by clarifying the regulatory framework governing drug preclusion, and for other purposes.

Based on the bill's title, this measure would amend the Federal Food, Drug, and Cosmetic Act to modify the regulatory framework for dietary supplements, specifically addressing rules that prevent a substance from being marketed as both a drug and a dietary supplement. The bill aims to encourage innovation in the dietary supplement industry and expand consumer access to such products. The specific mechanisms and scope of these changes are not available from the title alone.

Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.